OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Release Date
2023
(4)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Not available
S-EPMC10946605
|
biostudies-literature
Cite
The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Not available
S-EPMC10629760
|
biostudies-literature
Cite
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis.
Not available
S-EPMC10278381
|
biostudies-literature
Cite
Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
Not available
S-EPMC10186210
|
biostudies-literature
Cite
Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma.
Not available
S-EPMC4864952
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets